Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences Market Cap 2006-2020 | GILD

Gilead Sciences market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Gilead Sciences market cap as of October 27, 2020 is $75.17B.
  
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $75.173B $22.449B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $135.015B 10.40
Amgen (AMGN) United States $131.717B 14.31
CSL (CSLLY) Australia $95.198B 0.00
Regeneron Pharmaceuticals (REGN) United States $62.318B 23.83
Vertex Pharmaceuticals (VRTX) United States $53.956B 30.11
Illumina (ILMN) United States $46.583B 54.17
Biogen (BIIB) United States $39.511B 7.02
Seattle Genetics (SGEN) United States $34.074B 0.00
Moderna (MRNA) United States $27.716B 0.00
BeiGene (BGNE) Cayman Islands $27.306B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.467B 11.03
Genmab (GMAB) Denmark $22.905B 14.45
Genmab (GNMSF) Denmark $21.264B 4.90
Incyte (INCY) United States $19.779B 0.00
BioNTech SE (BNTX) Germany $18.764B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.541B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.079B 77.25
Exact Sciences (EXAS) United States $16.003B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.953B 37.33
Alnylam Pharmaceuticals (ALNY) United States $14.922B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.942B 101.16
MyoKardia (MYOK) United States $11.820B 0.00
ARGENX SE-ADR (ARGX) Netherlands $11.725B 0.00
QIAGEN (QGEN) Netherlands $11.219B 28.47
Sarepta Therapeutics (SRPT) United States $10.882B 0.00
Guardant Health (GH) United States $10.231B 0.00
Bio-Techne Corp (TECH) United States $10.200B 69.99
Repligen (RGEN) United States $9.321B 147.95
Mirati Therapeutics (MRTX) United States $8.760B 0.00
Ascendis Pharma (ASND) Denmark $8.382B 0.00
Galapagos (GLPG) Belgium $8.316B 30.09
ACADIA Pharmaceuticals (ACAD) United States $7.075B 0.00
Adaptive Biotechnologies (ADPT) United States $6.783B 0.00
Exelixis (EXEL) United States $6.767B 24.61
CRISPR Therapeutics AG (CRSP) Switzerland $6.605B 204.63
Acceleron Pharma (XLRN) United States $6.493B 0.00
Blueprint Medicines (BPMC) United States $5.702B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.529B 0.00
Novavax (NVAX) United States $5.354B 0.00
Emergent Biosolutions (EBS) United States $5.043B 19.98
SWEDISH ORP BIO (BIOVF) Sweden $4.959B 13.55
Arena Pharmaceuticals (ARNA) United States $4.929B 0.00
Amicus Therapeutics (FOLD) United States $4.852B 0.00
NeoGenomics (NEO) United States $4.633B 1398.33
Vir Biotechnology (VIR) United States $4.545B 0.00
Denali Therapeutics (DNLI) United States $4.460B 0.00
China Biologic Products (CBPO) China $4.445B 26.38
Halozyme Therapeutics (HALO) United States $4.225B 0.00
Fate Therapeutics (FATE) United States $4.073B 0.00
Reata Pharmaceuticals (RETA) United States $3.852B 0.00
Insmed (INSM) United States $3.744B 0.00
Twist Bioscience (TWST) United States $3.688B 0.00
Legend Biotech (LEGN) United States $3.581B 0.00
Bluebird Bio (BLUE) United States $3.544B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.537B 0.00
Global Blood Therapeutics (GBT) United States $3.469B 0.00
MorphoSys AG (MOR) Germany $3.346B 43.85
Eidos Therapeutics (EIDX) United States $2.826B 0.00
Alkermes (ALKS) Ireland $2.530B 53.03
PHARMA MAR SA (PHMMF) Spain $2.396B 0.00
I-Mab (IMAB) China $2.350B 0.00
Seres Therapeutics (MCRB) United States $2.276B 0.00
Sorrento Therapeutics (SRNE) United States $2.073B 0.00
Editas Medicine (EDIT) United States $2.001B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.938B 0.00
UniQure (QURE) Netherlands $1.931B 0.00
Amarin (AMRN) Ireland $1.901B 0.00
Zymeworks (ZYME) Canada $1.862B 0.00
Beam Therapeutics (BEAM) United States $1.846B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Viela Bio (VIE) United States $1.754B 0.00
Inovio Pharmaceuticals (INO) United States $1.751B 0.00
Intra-Cellular Therapies (ITCI) United States $1.673B 0.00
Revance Therapeutics (RVNC) United States $1.658B 0.00
Sangamo Therapeutics (SGMO) United States $1.578B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.513B 0.00
Intellia Therapeutics (NTLA) United States $1.439B 0.00
Zealand Pharma (ZEAL) Denmark $1.404B 0.00
Ligand Pharmaceuticals (LGND) United States $1.366B 46.16
Northwest Biotherapeutics (NWBO) United States $1.329B 0.00
Mersana Therapeutics (MRSN) United States $1.312B 0.00
Arcus Biosciences (RCUS) United States $1.288B 0.00
Epizyme (EPZM) United States $1.282B 0.00
Mesoblast (MESO) Australia $1.278B 0.00
Coherus BioSciences (CHRS) United States $1.269B 7.40
Zealand Pharma (ZLDPF) Denmark $1.264B 0.00
Alcobra (ARCT) United States $1.223B 0.00
NGM Biopharmaceuticals (NGM) United States $1.193B 0.00
Cytokineticsorporated (CYTK) United States $1.093B 0.00
REGENXBIO (RGNX) United States $1.085B 0.00
Heska (HSKA) United States $1.083B 0.00
Myriad Genetics (MYGN) United States $1.074B 0.00
Retrophin (RTRX) United States $1.069B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.058B 0.00
Genetron Holdings (GTH) China $1.019B 0.00
Castle Biosciences (CSTL) United States $1.003B 0.00
NantKwest (NK) United States $0.975B 0.00
Adverum Biotechnologies (ADVM) United States $0.958B 0.00
Athenex (ATNX) United States $0.955B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.951B 0.00
Compugen (CGEN) Israel $0.950B 0.00
Vericel (VCEL) United States $0.920B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.846B 0.00
Morphic Holding (MORF) United States $0.835B 0.00
Codexis (CDXS) United States $0.827B 0.00
Arvinas (ARVN) United States $0.826B 0.00
Pliant Therapeutics (PLRX) United States $0.805B 0.00
Alector (ALEC) United States $0.778B 0.00
AnaptysBio (ANAB) United States $0.757B 0.00
Cellectis S.A (CLLS) France $0.755B 0.00
Frequency Therapeutics (FREQ) United States $0.751B 0.00
Intrexon (PGEN) United States $0.733B 0.00
Protagonist Therapeutics (PTGX) United States $0.713B 0.00
Pharming Group (PHGUF) Netherlands $0.682B 15.57
Agenus (AGEN) United States $0.670B 0.00
MiMedx (MDXG) United States $0.656B 0.00
Cara Therapeutics (CARA) United States $0.653B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Adaptimmune Therapeutics (ADAP) United Kingdom $0.634B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.631B 0.00
Celldex Therapeutics (CLDX) United States $0.603B 0.00
Kadmon Holdings (KDMN) United States $0.581B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.570B 4.99
VBI Vaccines (VBIV) United States $0.569B 0.00
Geron (GERN) United States $0.568B 0.00
IVERIC Bio (ISEE) United States $0.534B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.503B 0.00
Cel-Sci (CVM) United States $0.499B 0.00
Albireo Pharma (ALBO) United States $0.495B 0.00
Anika Therapeutics (ANIK) United States $0.492B 21.52
MeiraGTx Holdings (MGTX) United States $0.486B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.486B 0.00
MannKind (MNKD) United States $0.477B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.472B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.468B 0.00
Clovis Oncology (CLVS) United States $0.462B 0.00
Prothena (PRTA) Ireland $0.453B 0.00
UROGEN PHARMA (URGN) United States $0.440B 0.00
Sutro Biopharma (STRO) United States $0.439B 0.00
Amryt Pharma (AMYT) United Kingdom $0.438B 0.00
Kala Pharmaceuticals (KALA) United States $0.433B 0.00
Dynavax Technologies (DVAX) United States $0.430B 0.00
Avid Bioservices (CDMO) United States $0.428B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.424B 0.00
Starpharma Holdings (SPHRY) Australia $0.419B 0.00
Scholar Rock Holding (SRRK) United States $0.410B 0.00
Merus (MRUS) Netherlands $0.380B 0.00
Puma Biotechnology (PBYI) United States $0.378B 0.00
Forte Biosciences (FBRX) United States $0.373B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.367B 0.00
Cue Biopharma (CUE) United States $0.363B 0.00
Cellular Biomedicine (CBMG) United States $0.356B 0.00
ANI Pharmaceuticals (ANIP) United States $0.351B 8.29
Kamada (KMDA) Israel $0.350B 16.72
AC Immune SA (ACIU) Switzerland $0.348B 0.00
Trevena (TRVN) United States $0.342B 0.00
Spero Therapeutics (SPRO) United States $0.342B 0.00
Cardiff Oncology (CRDF) United States $0.340B 0.00
Precision BioSciences (DTIL) United States $0.340B 0.00
Selecta Biosciences (SELB) United States $0.335B 0.00
Athersys (ATHX) United States $0.334B 0.00
IBio (IBIO) United States $0.334B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.331B 0.00
BioDelivery Sciences (BDSI) United States $0.329B 23.29
Aeglea BioTherapeutics (AGLE) United States $0.323B 0.00
Innate Pharma S.A (IPHA) France $0.316B 0.00
Syros Pharmaceuticals (SYRS) United States $0.313B 0.00
CytomX Therapeutics (CTMX) United States $0.307B 0.00
NextCure (NXTC) United States $0.301B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.295B 0.00
ChromaDex (CDXC) United States $0.294B 0.00
WAVE Life Sciences (WVE) Singapore $0.279B 0.00
XOMA (XOMA) United States $0.259B 0.00
PDL BioPharma (PDLI) United States $0.254B 0.00
Affimed (AFMD) Germany $0.245B 0.00
Pluristem Therapeutics (PSTI) Israel $0.243B 0.00
TELA Bio (TELA) United States $0.236B 0.00
Arbutus Biopharma (ABUS) United States $0.229B 0.00
Fortress Biotech (FBIO) United States $0.222B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.216B 0.00
Dyadic (DYAI) United States $0.212B 0.00
HOOKIPA Pharma (HOOK) United States $0.209B 0.00
Verastem (VSTM) United States $0.207B 0.00
Five Prime Therapeutics (FPRX) United States $0.200B 0.00
ADMA Biologics Inc (ADMA) United States $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Eton Pharmaceuticals (ETON) United States $0.184B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.180B 0.00
CorMedix Inc (CRMD) United States $0.177B 0.00
Liquidia Technologies (LQDA) United States $0.169B 0.00
GENFIT S.A (GNFT) France $0.169B 0.00
Cerecor (CERC) United States $0.169B 0.00
DBV Technologies S.A (DBVT) France $0.168B 0.00
Biofrontera AG (BFRA) Germany $0.166B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.159B 0.00
Kindred Biosciences (KIN) United States $0.158B 0.00
Theratechnologies (THTX) Canada $0.156B 0.00
Nicox SA (NICXF) France $0.149B 0.00
VolitionRX (VNRX) United States $0.146B 0.00
Bellus Health (BLU) Canada $0.145B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.144B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.144B 6.70
Checkpoint Therapeutics (CKPT) United States $0.142B 0.00
Aptinyx (APTX) United States $0.140B 0.00
Applied Genetic Technologies (AGTC) United States $0.137B 0.00
Prometic Life Sciences (LMNL) Canada $0.135B 0.00
Exicure (XCUR) United States $0.134B 0.00
SESEN BIO, INC (SESN) United States $0.130B 0.00
Aytu Bioscience (AYTU) United States $0.128B 0.00
Cidara Therapeutics (CDTX) United States $0.128B 0.00
AquaBounty Technologies (AQB) United States $0.126B 0.00
Catalyst Biosciences (CBIO) United States $0.126B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.125B 0.00
Unum Therapeutics (COGT) United States $0.124B 0.00
Lumos Pharma (LUMO) United States $0.120B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.113B 0.00
Celyad SA (CYAD) Belgium $0.112B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
Strongbridge Biopharma (SBBP) United States $0.111B 0.00
Gritstone Oncology (GRTS) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.109B 5.53
Abeona Therapeutics (ABEO) United States $0.107B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.102B 0.00
Antibe Therapeutics (ATBPF) Canada $0.099B 0.00
Oncobiologics (OTLK) United States $0.097B 0.00
AIT Therapeutics (XAIR) United States $0.096B 0.00
Enzo Biochem (ENZ) United States $0.095B 0.00
Palatin Technologies (PTN) United States $0.089B 0.00
Cyclerion Therapeutics (CYCN) United States $0.088B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.086B 0.00
Ecology Coatings (ABVC) United States $0.086B 0.00
Idera Pharmaceuticals (IDRA) United States $0.083B 0.00
DiaMedica Therapeutics (DMAC) United States $0.080B 0.00
ARAVIVE, INC (ARAV) United States $0.079B 0.00
Evogene (EVGN) Israel $0.075B 0.00
Bionano Genomics (BNGO) United States $0.075B 0.00
Stealth BioTherapeutics (MITO) United States $0.075B 72.00
Prima BioMed (IMMP) Australia $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Appili Therapeutics (APLIF) Canada $0.064B 0.00
AmpliPhi Biosciences (ARMP) United States $0.062B 0.00
Clearside Biomedical (CLSD) United States $0.061B 0.00
Curis (CRIS) United States $0.060B 0.00
Edesa Biotech (EDSA) Canada $0.060B 0.00
TRACON Pharmaceuticals (TCON) United States $0.057B 0.00
Proteostasis Therapeutics (PTI) United States $0.056B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.055B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.054B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.052B 0.00
Soligenix (SNGX) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Cocrystal Pharma (COCP) United States $0.045B 0.00
Genetic Technologies (GENE) Australia $0.045B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
Acorda Therapeutics (ACOR) United States $0.043B 0.00
Novogen (KZIA) Australia $0.041B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
CollPlant Holdings (CLGN) Israel $0.040B 0.00
Vaccinex (VCNX) United States $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.039B 0.00
Pulmatrix (PULM) United States $0.038B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Apricus Biosciences (SEEL) United States $0.034B 0.00
Cleveland BioLabs (CBLI) United States $0.033B 0.00
ATyr Pharma (LIFE) United States $0.033B 0.00
OvaScience (MLND) United States $0.031B 0.00
Advaxis (ADXS) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
BioCardia (BCDA) United States $0.026B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Celsion (CLSN) United States $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Alimera Sciences (ALIM) United States $0.022B 0.00
Spherix (AIKI) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.015B 0.00
Titan Pharmaceuticals (TTNP) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.003B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00